Call Us
+919016820285
Contact Us For Help
Products
Home » Products » Antimalarial Drugs » Artesunate, Sulphadoxine & Pyrimethamine Tablets

Artesunate, Sulphadoxine & Pyrimethamine Tablets

Artesunate, Sulphadoxine & Pyrimethamine Tablets
Artesunate, Sulphadoxine & Pyrimethamine Tablets
Send Inquiry
Product Code : Artesunate, Sulphadoxine & Pyrimethamine Tablets
Brand Name : Falciart kit
Price And Quantity
  • Minimum Order Quantity
  • As required by client. Box/Boxes
  • Price
  • 0.99 USD ($)
Product Specifications
  • Drug Type
  • Specific Drug
  • Ingredients
  • Artesunate, Sulphadoxine & Pyrimethamine Available Strength : 100mg + 500mg + 25mg
  • Physical Form
  • Tablets
  • Function
  • Anti-Malaria
  • Recommended For
  • Antimalarial
  • Dosage
  • As directed by physician
  • Dosage Guidelines
  • As directed by physician
  • Suitable For
  • Suitable For All
  • Storage Instructions
  • Store in cool & dry place
Product Description

Description

PRODUCT DESCRIPTION

Artesunate + Sulfadoxine + Pyrimethamine Tablet is a fixed-dose combination that contains three active ingredients against uncomplicated malaria parasites. Artesunate + Sulfadoxine / Pyrimethamine Tablets are a curative treatment for all forms of malaria and have been specially designed to treat malaria in 24 hours in children, adolescents and adults.

Artesunate is a semi-synthetic derivative of artemisinin that is water-soluble and is used for the treatment of severe falciparum malaria in areas where there is evidence of quinine resistance. Artesunate should always be administered with Mefloquine in a full therapeutic dose.

Sulfadoxine 500mg + Pyramethamine 25mg is an antimalarial agent that acts by reciprocal potentiation of its two components, achieved by a sequential blockade of two enzymes involved in the biosynthesis of folinic acid within the parasites. It is effective against certain strains of Plasmodium falciparum that are resistant to chloroquine. Both the sulfadoxine and the pyramethamine are absorbed orally and are excreted mainly by the kidney.

This is an Artemisinin-based combination therapy (ACT) which is recommended by the World Health Organization (WHO) for the treatment of all forms of Malaria.

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc

Trade Information
  • FOB Port
  • Hazira / Nhava Sheva
  • Payment Terms
  • Letter of Credit (L/C), Cash in Advance (CID), Telegraphic Transfer (T/T), Cash Advance (CA)
  • Supply Ability
  • 5 Million Tablet Per Month
  • Delivery Time
  • 1 Week
  • Sample Available
  • Yes
  • Sample Policy
  • If order is confirmed we will reimburse the sample cost
  • Packaging Details
  • Single CombiKit
  • Main Domestic Market
  • All India
  • Certifications
  • WHO GMP COA (As Per Clients Requirement)

SALVAVIDAS PHARMACEUTICAL PVT. LTD.
X